InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RZR | Ann: Removal from official list (COB 29/03/12) | 28/03/12 | 0 | 328 | |||
|
|||||||
RZR | Ann: TMX Group Close of Offer for Razor Risk Tech | 29/02/12 | 0 | 288 | |||
|
|||||||
RZR | Ann: Change in substantial holding | 27/02/12 | 0 | 267 | |||
|
|||||||
RZR | Ann: Suspension from Official Quotation (close 24 | 24/02/12 | 0 | 249 | |||
|
|||||||
RZR | half-year report | 24/02/12 | 1 | 417 | |||
|
|||||||
RZR | Ann: Notice of Status of Conditions | 20/02/12 | 0 | 285 | |||
|
|||||||
RZR | Ann: Change to Chief Executive Officer | 17/02/12 | 0 | 221 | |||
|
|||||||
RZR | Ann: Compulsory Acquisition Notice | 17/02/12 | 0 | 224 | |||
|
See All Discussions